{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-2007-D-0369\" and posted_year = 2013 sorted by posted_date descending", "rows": [["FDA-2007-D-0369-0279", "FDA", "FDA-2007-D-0369", "Marc Bloomenstein (Schwartz Laser Eye Center) - Letter", "Other", "Letter(s)", "2013-12-12T05:00:00Z", 2013, 12, "2013-12-12T05:00:00Z", null, "2013-12-12T17:47:56Z", null, 0, 0, "090000648147aac5"], ["FDA-2007-D-0369-0278", "FDA", "FDA-2007-D-0369", "Supplement from Alison Manson (Prevent Blindness America)", "Other", "Supplement (SUP)", "2013-12-12T05:00:00Z", 2013, 12, "2013-12-12T05:00:00Z", null, "2014-11-17T17:35:28Z", null, 0, 0, "090000648147aac6"], ["FDA-2007-D-0369-0277", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry; Availability: Bioequivalence Recommendations for Paliperidone Palmitate Extended-Release Injectable Suspension", "Notice", "Notice of Availability", "2013-12-05T05:00:00Z", 2013, 12, "2013-12-05T05:00:00Z", "2014-02-04T04:59:59Z", "2014-02-13T02:02:08Z", "2013-29080", 0, 0, "09000064814a9e1e"], ["FDA-2007-D-0369-0275", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry on Bioequivalence Recommendations for Fluticasone Propionate; Salmeterol Xinafoate; Reopening of the Comment Period", "Notice", "Notice of Availability", "2013-11-27T05:00:00Z", 2013, 11, "2013-11-27T05:00:00Z", "2013-12-12T04:59:59Z", "2013-12-08T18:23:54Z", "2013-28394", 0, 0, "090000648149c332"], ["FDA-2007-D-0369-0267", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry on Bioequivalence Recommendations for Iron Sucrose; Availability", "Notice", "Notice of Availability", "2013-11-06T05:00:00Z", 2013, 11, "2013-11-06T05:00:00Z", "2014-01-07T04:59:59Z", "2014-01-08T02:03:00Z", "2013-26570", 0, 0, "09000064814724f9"], ["FDA-2007-D-0369-0268", "FDA", "FDA-2007-D-0369", "Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability", "Notice", "Notice of Availability", "2013-11-06T05:00:00Z", 2013, 11, "2013-11-06T05:00:00Z", "2014-01-07T04:59:59Z", "2013-12-07T21:29:25Z", "2013-26546", 0, 0, "090000648147267c"], ["FDA-2007-D-0369-0264", "FDA", "FDA-2007-D-0369", "Aptalis Pharma US, Inc. - Request for Extension of Comment Period", "Other", "Request for Extension", "2013-10-30T04:00:00Z", 2013, 10, "2013-10-30T04:00:00Z", null, "2013-10-30T15:56:37Z", null, 0, 0, "090000648142e65c"], ["FDA-2007-D-0369-0261", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry on Bioequivalence Recommendations for Fluticasone Propionate; Salmeterol Xinafoate; Availability", "Notice", "Notice of Availability", "2013-09-10T04:00:00Z", 2013, 9, "2013-09-10T04:00:00Z", "2013-11-27T04:59:59Z", "2013-11-20T02:04:23Z", "2013-21892", 0, 0, "09000064813ebb62"], ["FDA-2007-D-0369-0244", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry; Bioequivalence Recommendations for Risperidone Injection; Availability", "Notice", "Guidance", "2013-08-26T04:00:00Z", 2013, 8, "2013-08-26T04:00:00Z", "2013-10-26T03:59:59Z", "2013-10-29T01:02:08Z", "2013-20696", 0, 0, "09000064813c3adb"], ["FDA-2007-D-0369-0235", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry on Bioequivalence Recommendations for Mesalamine Rectal Suppositories; Availability", "Notice", "Notice of Data Availability", "2013-08-02T04:00:00Z", 2013, 8, "2013-08-02T04:00:00Z", "2013-10-02T03:59:59Z", "2013-12-28T03:16:34Z", "2013-18629", 0, 0, "090000648138c7e7"], ["FDA-2007-D-0369-0229", "FDA", "FDA-2007-D-0369", "Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability", "Notice", "Notice of Availability", "2013-06-20T04:00:00Z", 2013, 6, "2013-06-20T04:00:00Z", "2013-08-20T03:59:59Z", "2013-08-28T01:02:26Z", "2013-14675", 0, 0, "0900006481334132"], ["FDA-2007-D-0369-0117", "FDA", "FDA-2007-D-0369", "Draft and Revised Draft Guidances; Availability: Product-Specific Bioequivalence Recommendations re FDA-2007-D-0369-0110", "Notice", "Notice of Availability", "2013-04-08T04:00:00Z", 2013, 4, "2013-04-08T04:00:00Z", "2013-06-08T03:59:59Z", "2013-06-12T01:01:25Z", "2013-08013", 0, 0, "0900006481280145"], ["FDA-2007-D-0369-0116", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry; Bioequivalence Recommendations for Metronidazole Vaginal Gel", "Other", "Guidance", "2013-04-01T04:00:00Z", 2013, 4, "2013-04-01T04:00:00Z", null, "2024-11-12T05:14:52Z", null, 1, 0, "0900006481253931"], ["FDA-2007-D-0369-0115", "FDA", "FDA-2007-D-0369", "Draft Guidance for Industry; Availability: Bioequivalence Recommendations for Metronidazole Vaginal Gel", "Notice", "Notice of Availability", "2013-03-29T04:00:00Z", 2013, 3, "2013-03-29T04:00:00Z", "2013-05-29T03:59:59Z", "2013-03-29T13:32:00Z", "2013-07296", 0, 0, "090000648124f0dd"], ["FDA-2007-D-0369-0112", "FDA", "FDA-2007-D-0369", "Osmotica Pharmaceutical - Supplemental", "Supporting & Related Material", "Studies and Reports", "2013-03-11T04:00:00Z", 2013, 3, null, null, "2013-03-11T19:11:39Z", null, 0, 0, "0900006481213ece"], ["FDA-2007-D-0369-0110", "FDA", "FDA-2007-D-0369", "Guidance for Industry: Bioequivalence Recommendations for Specific Products", "Other", "Guidance", "2013-02-27T05:00:00Z", 2013, 2, "2013-02-27T05:00:00Z", null, "2013-05-14T18:39:29Z", null, 0, 0, "0900006480f985f0"], ["FDA-2007-D-0369-0109", "FDA", "FDA-2007-D-0369", "Sun Pharmaceutical Industries Ltd. - Supplemental", "Other", "Supplement (SUP)", "2013-02-15T05:00:00Z", 2013, 2, "2013-02-15T05:00:00Z", null, "2013-02-26T00:37:54Z", null, 0, 0, "09000064811e5678"], ["FDA-2007-D-0369-0107", "FDA", "FDA-2007-D-0369", "Vifor Pharma Ltd (Sidley Austin LLP) - Supplement re FDA-2007-D-0369-0089", "Other", "Supplemental Comment", "2013-01-23T05:00:00Z", 2013, 1, "2013-01-23T05:00:00Z", null, "2013-01-23T16:35:34Z", null, 0, 0, "09000064811c2961"], ["FDA-2007-D-0369-0105", "FDA", "FDA-2007-D-0369", "Electronic Comment from Surgical Migraine Clinic", "Supporting & Related Material", "Electronic Comment (EC)", "2013-01-15T05:00:00Z", 2013, 1, null, null, "2015-03-13T04:25:11Z", null, 0, 0, "090000648042bb8d"]], "truncated": false, "filtered_table_rows_count": 19, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2007-D-0369", "p2": "2013"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013", "results": [{"value": "FDA", "label": "FDA", "count": 19, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2013", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013", "results": [{"value": "Notice", "label": "Notice", "count": 10, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 7, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 2, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&document_type=Supporting+%26+Related+Material", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013", "results": [{"value": 2013, "label": 2013, "count": 19, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet=title"}, {"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-D-0369&posted_year=2013&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1761.2832899903879, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}